| FINANCIAL INSTRUMENTS |
The following table presents characteristics for certain of the Company’s financial instruments at June 30, 2026 and December 31, 2025. | | | | | | | | | | | | | | | | | | Financial Instruments (1) | | Balance Sheet Line Item | Type / Form | Measurement Basis | June 30, 2026 | | December 31, 2025 | | Assets | | (dollars in thousands) | | | | | | | | Securities | Agency mortgage-backed securities (2) | Fair value, with unrealized gains (losses) through other comprehensive income | $ | 6,014,557 | | | $ | 6,462,112 | | | Securities | Agency mortgage-backed securities (3) | Fair value, with unrealized gains (losses) through earnings | 81,754,021 | | | 83,166,542 | | | | | | | | | Securities | Residential credit risk transfer securities | Fair value, with unrealized gains (losses) through earnings | 46,872 | | | 213,800 | | | Securities | Non-agency mortgage-backed securities | Fair value, with unrealized gains (losses) through earnings | 1,565,016 | | | 1,445,176 | | | | | | | | | Securities | Commercial real estate debt investments - CMBS | Fair value, with unrealized gains (losses) through earnings | 135,019 | | | — | | | | | | | | | Total securities | | | 89,515,485 | | | 91,287,630 | | | | | | | | | Loans, net | Residential mortgage loans | Fair value, with unrealized gains (losses) through earnings | 7,280,979 | | | 5,020,784 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Interests in MSR | Interest in net servicing cash flows | Fair value, with unrealized gains (losses) through earnings | 106,775 | | | 28,626 | | | | | | | | | Assets transferred or pledged to securitization vehicles | Residential mortgage loans | Fair value, with unrealized gains (losses) through earnings | 38,256,690 | | | 32,067,433 | | | | | | | | | | | | | | | | | | | | | | | | | | Reverse repurchase agreements | Reverse repurchase agreements | Amortized cost | 33,047 | | | 34,389 | | | Liabilities | | | | | | Repurchase agreements | Repurchase agreements | Amortized cost | $ | 86,895,874 | | | $ | 81,865,723 | | | Other secured financing | Loans | Amortized cost | 1,125,000 | | | 1,075,000 | | | Debt issued by securitization vehicles | Securities | Fair value, with unrealized gains (losses) through earnings | 34,366,098 | | | 28,918,753 | | | Participations issued | Participations issued | Fair value, with unrealized gains (losses) through earnings | 2,553,709 | | | 1,932,655 | | | U.S. Treasury securities sold, not yet purchased | Securities | Fair value, with unrealized gains (losses) through earnings | — | | | 2,396,724 | | | | | | | | | | | | | | (1) Receivable for unsettled trades, Principal and interest receivable, Payable for unsettled trades, Interest payable and Dividends payable are accounted for at cost. Interests in MSR are considered financial instruments whereas directly held MSR are considered servicing assets or obligations. (2) Includes Agency pass-through, collateralized mortgage obligation (“CMO”) and multifamily securities purchased prior to July 1, 2022. (3) Includes interest-only securities and reverse mortgages and, effective July 1, 2022, newly purchased Agency pass-through, CMO and multifamily securities. |
|